Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:e112-e113

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SoRelle, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SoRelle, R.

(Circulation. 1999;100:e112.)
© 1999 American Heart Association, Inc.


Circulation Electronic Pages

Women and Heart Disease

Ruth SoRelle, MPH, Circulation Newswriter


*    A Secret in the Heart of French Women
 
For those in search of the solution to the French paradox, Dr Michel de Lorgeril has a suggestion: "Cherchez les femmes."

The differences in the rates of heart disease between the residents of nations where the Mediterranean diet is followed and the rest of Europe and the United States are well known, said Dr de Lorgeril, a researcher at Explorations Fonctionnelles Cardiorespiratoires et Metaboliques at the University of St. Etienne in France. However, the French are much more likely to eat like their northern European neighbors and yet experience heart disease rates more like people who live in nations to the south. For example, he said, mortality from coronary heart disease in British men aged 55 to 64 years was 487 per 100 000 in 1992; it was only 128 in French men. For women, the corresponding numbers were 128 in Britain and 27 in France. However, the 2 national groups reported similar risk factors, including an almost equal consumption of fat (Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ. 1999;318:1471–1476).


*    The Chaos of Vitamin E
 
The bottom line of the Cambridge Heart Antioxidant (CHAOS) trial, which sought to determine the effect of vitamin E on the risk of myocardial infarction and cardiovascular disease–related death, is that "we don’t know enough," said Nigel Stephens, MD, a consultant in cardiology at the University of London who led the study.

Of the 2002 patients enrolled in the trial, 1035 took vitamin E in doses of either 800 or . . . [Full Text of this Article]